Archives
-
1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine Control
2026-09-09
PP 3 is a practical negative-control reagent for separating PP 2-specific effects from vehicle, scaffold, and pathway artifacts in Src kinase signaling pathway research. This workflow connects matched chemical controls with vascular contraction, ROS, and L-type calcium-channel assays highlighted by a recent rat artery study.
-
Nintedanib (BIBF 1120) in ATRX-Stratified Glioma
2026-09-08
Use Nintedanib (BIBF 1120) to interrogate coordinated VEGFR, FGFR, and PDGFR blockade in genotype-defined cancer models. This workflow combines ATRX stratification, apoptosis profiling, and temozolomide combination testing while addressing formulation and exposure challenges.
-
PD0325901: MEK Inhibition for Cancer Research
2026-09-07
PD0325901 is a selective MEK inhibitor that suppresses ERK phosphorylation and produces cell-cycle and apoptosis-associated phenotypes in cancer models. Product-reported xenograft findings support its use as a research tool for studying RAS/RAF/MEK/ERK signaling pathway inhibition, not as a diagnostic or medical treatment.
-
Concerted PDA Drug Screening with Rgs16::GFP and JQ1
2026-09-07
Layeghi-Ghalehsoukhteh and colleagues developed a coordinated cell-culture and in vivo screening workflow using Rgs16::GFP to identify drug combinations active against pancreatic ductal adenocarcinoma. The study showed that histone deacetylase inhibition enhanced gemcitabine and JQ1 activity, while the reporter supported rapid prioritization of combinations for validation in genetically engineered mouse models.
-
EdU Cell Proliferation Kit: S-Phase Assay Guide
2026-09-05
The EdU Cell Proliferation Kit (TMB) is a non-radioactive 5-ethynyl-2'-deoxyuridine proliferation assay for measuring DNA synthesis during S phase. Its EdU–biotin click-labeling workflow couples CuAAC specificity to HRP-streptavidin and TMB colorimetric detection.
-
SGI-1027: Interpreting DNMT Assay Responses
2026-09-05
SGI-1027 is a DNA methyltransferase inhibitor whose effects extend beyond a single viability value. This guide explains how to connect DNMT inhibition, methylation changes, gene reactivation, proliferation arrest, and cell death in more informative cancer epigenetics assays.
-
KPT330 Improves Cas9 Precision Through mRNA Export
2026-09-04
The reference study identified selective inhibitors of nuclear export, particularly KPT330, as indirect modulators of CRISPR-Cas9 activity. By limiting the nuclear export of Cas9 mRNA rather than binding Cas9 protein, these compounds improved the reported precision of genome- and base-editing systems in human cells.
-
Tranexamic Acid Workflows for Clot Research
2026-09-04
Build reproducible fibrinolysis and clot-stability experiments with Tranexamic Acid, from plasmin inhibition assays to biomaterial screening. This workflow translates a 2024 composite wound-dressing study into practical concentration control, readout selection, and troubleshooting decisions.
-
NSP15 Screening Identifies Thymopentin and Oleuropein
2026-09-03
A 2021 structure-based study screened a natural-product library against the SARS-CoV-2 endoribonuclease NSP15 and identified thymopentin and oleuropein as leading computational inhibitors. Molecular-dynamics analysis supported stable protein–ligand complexes, but biochemical and cellular validation remains necessary before these candidates can be considered antiviral interventions.
-
POx-Lipid LNPs as PEG Alternatives for mRNA
2026-09-02
Holick and colleagues investigated poly(2-ethyl-2-oxazoline)-based lipids as substitutes for PEG-lipids in mRNA lipid nanoparticles. By varying polymer chain length and combining physicochemical, immunological, transfection, and super-resolution imaging analyses, the study identified a PEtOx-LNP formulation that outperformed the commercial PEG-lipid benchmark used in Comirnaty.
-
Cyanine 3 Tyramide for Neural Signal Mapping
2026-09-02
Cyanine 3 Tyramide combines orange fluorescence with enzyme-driven deposition to reveal low-abundance molecular signals in tissue, cells, and spatial neuroscience assays. This guide connects practical TSA workflows with the early-life-adversity and oxytocin findings reported in a recent mouse study, while emphasizing validation, multiplexing, and troubleshooting.
-
Exemestane: From Aromatase Mechanism to Translation
2026-09-02
A mechanism-first guide to using Exemestane in breast cancer research, from irreversible aromatase inactivation and assay design to biomarker-aware translational strategy.
-
Genistein and Mechanostress: Better Cancer Assays
2026-09-01
Genistein can help connect growth-factor signaling, cell proliferation inhibition, and cancer chemoprevention studies with emerging mechanotransduction research. This guide explains how to use it as a controlled perturbation without confusing kinase effects with cytoskeleton-dependent autophagy.
-
EZ Cap EGFP mRNA 5-moUTP: Delivery Guide
2026-08-31
EZ Cap EGFP mRNA 5-moUTP is more than a fluorescent reporter: it is a controlled probe for separating transcript quality, delivery, translation, and cellular response. This guide connects its Cap1, 5-moUTP, and poly(A) design with hybrid nanoparticle evidence to improve assay interpretation from cultured cells to in vivo imaging.
-
Y-27632: Practical ROCK Inhibitor Workflow
2026-08-31
Y-27632 provides a reversible, ATP-competitive approach for testing ROCK1 and ROCK2 involvement in cytoskeletal organization and cell-based assays. This guide covers dossier-supported handling and workflow recommendations, but it should not be treated as clinical guidance or as evidence for outcomes in models lacking directly matched literature.